4TEEN4 PHARMACEUTICALS
4TEEN4 Pharmaceuticals GmbH is a biopharmaceutical company developing Procizumab, a humanized antibody targeting human Dipeptidyl Peptidase 3 (DPP3) for the treatment of acute cardiovascular diseases.
4TEEN4 PHARMACEUTICALS
Industry:
Biotechnology Health Care Health Diagnostics Hospital Medical Medical Device
Founded:
2002-01-01
Address:
Hennigsdorf, Brandenburg, Germany
Country:
Germany
Website Url:
http://www.4teen4.de
Total Employee:
11+
Status:
Active
Contact:
+49 33 02/2 05 65-0
Email Addresses:
[email protected]
Total Funding:
38.86 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Google Universal Analytics Apache
Similar Organizations
Flamentera
Flamentera AG develops non-invasive tests for lifelong monitoring of celiac patients.
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Natural Diagnostics
Natural Diagnostics has develops environmentally friendly pregnancy tests and ovulation tests with 85% less plastic than conventional tests.
Reavita
Reavita is specialized in diagnostics, resuscitation and simulation for medical laypersons and medical professionals.
SomaLogic
SomaLogic is a protein biomarker discovery and clinical diagnostics company, offers SOMAmer technology to improve diagnostic products.
Sphingotec GmbH
SphingoTec GmbH develops innovative biomarkers for diagnosis, prediction and monitoring of acute medical conditions.
xRapid
xRapid is a mobile health diagnosis through disruptive solutions leveraging the use of artificial intelligence.
Current Advisors List
Current Employees Featured
Founder
Investors List
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Convertible Note - 4TEEN4 Pharmaceuticals
Brandenburg Kapital
Brandenburg Kapital investment in Series A - 4TEEN4 Pharmaceuticals
HBM Partners
HBM Partners investment in Venture Round - 4TEEN4 Pharmaceuticals
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Venture Round - 4TEEN4 Pharmaceuticals
Wellington Partners
Wellington Partners investment in Venture Round - 4TEEN4 Pharmaceuticals
Brandenburg Kapital
Brandenburg Kapital investment in Venture Round - 4TEEN4 Pharmaceuticals
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - 4TEEN4 Pharmaceuticals
Official Site Inspections
http://www.4teen4.de
- Host name: 185.82.85.187
- IP address: 185.82.85.187
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
